PTEN and neoplasm: Furthermore, loss of PTEN, a PI3K‐regulator and tumor suppressor, is more frequent in the ultralow risk tumors, and PIK3CA‐mutations, which have been associated with more favorable outcome in ER‐positive breast cancer,41 are more common.